Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

Delayed Quote. Delayed  - 04/29 05:35:11 pm
1459 GBp   -2.01%
04/29 GLAXOSMITHKLINE : Glaxo, Save The Children Get Positive Opinion On A..
04/28DJGLAXOSMITHKLINE : CEO Sells 10,000 Shares/1,475P
04/28 GLAXOSMITHKLINE : *hsbc raises glaxosmithkline price target to 1865 ..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201320142015201620172018
Sales26 50523 00623 92325 50126 30227 404
Operating income (EBITDA)8 8838 0457 0288 2318 7119 228
Operating profit (EBIT)8 0156 5945 7296 6466 8687 454
Pre-Tax Profit (EBT)6 6472 96810 5264 3755 1426 011
Net income5 6282 7568 4222 7733 4024 213
P/E ratio0,150,240,0829,222,919,0
EPS (PNC )11156,717249,963,776,6
Dividend per Share (PNC )78,080,080,081,780,081,5
Yield484%581%583%5,60%5,48%5,59%
Reference price (PNC )16.113.813.7145914591459
Announcement Date02/05/2014
12:00pm
02/04/2015
03:18pm
02/03/2016
12:00pm
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201320142015201620172018
Debt12 64514 37710 72712 67512 82912 457
Finance------
Operating income (EBITDA)8 8838 0457 0288 2318 7119 228
Leverage
(Debt/EBITDA)
1,42x1,79x1,53x1,54x1,47x1,35x
Capital Expenditure1 1881 1881 3801 7221 5181 437
Book Value Per Share (BVPS)146 PNC87,6 PNC106 PNC71,0 PNC68,1 PNC77,8 PNC
Cash Flow per Share149 PNC108 PNC53,2 PNC106 PNC126 PNC134 PNC
Announcement Date02/05/2014
12:00pm
02/04/2015
03:18pm
02/03/2016
12:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 71 064 M GBP -
Entreprise Value (EV) 83 739 M GBP 83 893 M GBP
Valuation 2016e 2017e
P/E ratio (Price / EPS) 29,2x 22,9x
Capitalization / Revenue 2,79x 2,70x
EV / Revenue 3,28x 3,19x
EV / EBITDA 10,2x 9,63x
Yield (DPS / Price) 5,60% 5,48%
Price to book (Price / BVPS) 20,6x 21,4x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 26,1% 26,1%
operating Leverage (Delta EBIT / Delta Sales) 2,43x 1,06x
Net Margin (Net Profit / Revenue) 10,9% 12,9%
ROA (Net Profit / Asset) 7,20% 8,44%
ROE (Net Profit / Equities) 86,6% 117%
Rate of Dividend 164% 126%
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   6,75% 5,77%
Cash Flow / Sales 20,3% 23,3%
Capital Intensity (Assets / Sales) 1,51x 1,53x
Financial Leverage (Net Debt / EBITDA) 1,54x 1,47x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend